Literature DB >> 16279910

Inappropriate colorectal cancer screening: findings and implications.

Deborah A Fisher1, Latisha Judd, Nadia S Sanford.   

Abstract

OBJECTIVES: Inclusion of colorectal cancer screening as a performance measure in the Veterans Health Administration (VHA) health system appears to have improved screening rates but may have also increased inappropriate screening. Our aim was to ascertain whether the fecal occult blood test (FOBT) was being ordered appropriately.
METHODS: We examined records of 500 consecutive primary care patients at a single VHA facility for whom FOBT had been ordered to determine whether the FOBT was appropriate and, if not, the reason why.
RESULTS: We found that 18% of the sample had severe comorbid illness, 13% had signs or symptoms of gastrointestinal blood loss, 7% had a history of colorectal neoplasia or inflammatory bowel disease (high risk), 5% had undergone colonoscopy within prior 5 yr, and 3% were younger than 50 yr of age. Overall, 35% of the patients had at least one reason that the FOBT was inappropriate and at least 19% of the patients should not have undergone any colorectal cancer test for screening or diagnosis.
CONCLUSIONS: The FOBT order was inappropriate in a third of the sample, most commonly because of a documented life-limiting comorbidity. In addition, data suggested that FOBT was being used for diagnosis instead of screening. Screening patients unlikely to live long enough to develop and die from colorectal cancer provides no benefit and places these individuals at unjustifiable risk. Additionally, inappropriate screening utilizes resources that could be used to improve screening and follow-up for eligible individuals.

Entities:  

Mesh:

Year:  2005        PMID: 16279910     DOI: 10.1111/j.1572-0241.2005.00322.x

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  20 in total

1.  Attitude of the Italian general population towards prevention and screening of the most common tumors, with special emphasis on colorectal malignancies.

Authors:  Federica Domati; Estratios Travlos; Claudia Cirilli; Giuseppina Rossi; Piero Benatti; Massimiliano Marino; Giovanni Ponti; Maria Vandelli; Simone Valmori; Amal Oursana; Annalisa Pezzi; Maurizio Ponz de Leon
Journal:  Intern Emerg Med       Date:  2008-09-20       Impact factor: 3.397

2.  Levels and variation in overuse of fecal occult blood testing in the Veterans Health Administration.

Authors:  Melissa R Partin; Adam A Powell; Ann Bangerter; Krysten Halek; James F Burgess; Deborah A Fisher; David B Nelson
Journal:  J Gen Intern Med       Date:  2012-07-19       Impact factor: 5.128

3.  Five common errors to avoid in clinical practice: the Italian Association of Hospital Gastroenterologists and Endoscopists (AIGO) Choosing Wisely Campaign.

Authors:  Elisa Stasi; Andrea Michielan; Gaetano Cristian Morreale; Alessandro Tozzi; Ludovica Venezia; Francesco Bortoluzzi; Omero Triossi; Marco Soncini; Gioacchino Leandro; Giuseppe Milazzo; Andrea Anderloni
Journal:  Intern Emerg Med       Date:  2018-11-29       Impact factor: 3.397

4.  Screening practices of Australian men and women categorized as "at or slightly above average risk" of colorectal cancer.

Authors:  Driss Ait Ouakrim; Trevor Lockett; Alex Boussioutas; Louise Keogh; Louisa B Flander; Ingrid Winship; Graham G Giles; John L Hopper; Mark A Jenkins
Journal:  Cancer Causes Control       Date:  2012-09-26       Impact factor: 2.506

5.  Influence of Age and Comorbidity on Colorectal Cancer Screening in the Elderly.

Authors:  Carrie N Klabunde; Yingye Zheng; Virginia P Quinn; Elisabeth F Beaber; Carolyn M Rutter; Ethan A Halm; Jessica Chubak; Chyke A Doubeni; Jennifer S Haas; Aruna Kamineni; Marilyn M Schapira; Pamela M Vacek; Michael P Garcia; Douglas A Corley
Journal:  Am J Prev Med       Date:  2016-06-22       Impact factor: 5.043

6.  Potentially inappropriate screening colonoscopy in Medicare patients: variation by physician and geographic region.

Authors:  Kristin M Sheffield; Yimei Han; Yong-Fang Kuo; Taylor S Riall; James S Goodwin
Journal:  JAMA Intern Med       Date:  2013-04-08       Impact factor: 21.873

7.  Assessing Colorectal Cancer Screening Adherence of Medicare Fee-for-Service Beneficiaries Age 76 to 95 Years.

Authors:  John Bian; Charles Bennett; Gregory Cooper; Alessandra D'Alfonso; Deborah Fisher; Joseph Lipscomb; Chao-Nan Qian
Journal:  J Oncol Pract       Date:  2016-05-17       Impact factor: 3.840

8.  Challenges in the management of positive fecal occult blood tests.

Authors:  Sandhya K Rao; Thad F Schilling; Thomas D Sequist
Journal:  J Gen Intern Med       Date:  2009-01-08       Impact factor: 5.128

9.  Impact of age and comorbidity on colorectal cancer screening among older veterans.

Authors:  Louise C Walter; Karla Lindquist; Sean Nugent; Tammy Schult; Sei J Lee; Michele A Casadei; Melissa R Partin
Journal:  Ann Intern Med       Date:  2009-04-07       Impact factor: 25.391

10.  Comorbidity, age, race and stage at diagnosis in colorectal cancer: a retrospective, parallel analysis of two health systems.

Authors:  S Yousuf Zafar; Amy P Abernethy; David H Abbott; Steven C Grambow; Jennifer E Marcello; James E Herndon; Krista L Rowe; Jane T Kolimaga; Leah L Zullig; Meenal B Patwardhan; Dawn T Provenzale
Journal:  BMC Cancer       Date:  2008-11-25       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.